Citation Impact
Citing Papers
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
Lumbar intrathecal administration of naloxone antagonizes analgesia produced by electrical stimulation of the hypothalamic arcuate nucleus in pentobarbital-anesthetized rats
1990
Are poor metabolisers of sparteine/debrisoquine less pain tolerant than extensive metabolisers?
1993
Gastrointestinal motility disorders in scleroderma
1994 Standout
Phantom limb pain
2001 Standout
Gastrointestinal dysfunction in Parkinson's disease
2003 Standout
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Bowel Disorders
2016 Standout
Anatomy and regulation of the central melanocortin system
2005 Standout
Vagus-Dependent and Vagus-Independent Mechanisms of Action of the Erythromycin Derivative EM574 and Motilin in Dogs
1996 StandoutNobel
Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies
2002 Standout
Descending control of pain
2002 Standout
Functional and chemical anatomy of the afferent vagal system
2000 Standout
Expert Committee Recommendations Regarding the Prevention, Assessment, and Treatment of Child and Adolescent Overweight and Obesity: Summary Report
2007 Standout
International table of glycemic index and glycemic load values: 2002,
2002 Standout
Ischemic but Not Thermal Pain Sensitivity Varies Across the Menstrual Cycle
1997
The Otolaryngologic Manifestations of Gastroesophageal Reflux Disease (GERD): A Clinical Investigation of 225 Patients Using Ambulatory 24‐Hour pH Monitoring and an Experimental Investigation of the Role of Acid and Pepsin in the Development of Laryngeal Injury
1991 Standout
Biological actions of cholecystokinin
1994
Cisapride
1994
Irritable bowel syndrome in general practice: prevalence, characteristics, and referral
2000 Standout
Review article: 5‐hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications
1992
Esophageal Cancer
2003 Standout
Effects of Cisapride on Cholinergic Neurotransmission and Propulsive Motility in the Guinea Pig Ileum
1989
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Nutritional quality and health benefits of chickpea (Cicer arietinumL.): a review
2012 Standout
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Co‐localization of endomorphin‐2 and substance P in primary afferent nociceptors and effects of injury: a light and electron microscopic study in the rat
2004 StandoutNobel
Irritable bowel syndrome
2016 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Effects of age on concentrations of plasma cholecystokinin, glucagon-like peptide 1, and peptide YY and their relation to appetite and pyloric motility
1999
Functional Gut Disorders
1998
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Relationship of satiety to postprandial glycaemic, insulin and cholecystokinin responses
1992
Diclofenac residues as the cause of vulture population decline in Pakistan
2004 StandoutNature
Sarcopenia
2001 Standout
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
Postoperative ileus
1990
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?
2002 Standout
Oesophageal carcinoma
2013 Standout
The effect of opioids on phantom limb pain and cortical reorganization
2001
The Role of the Gut in Regulating Food Intake in Man
2009
The effect of cisapride on gastro‐oesophageal dysfunction in systemic sclerosis: a controlled manometric study.
1991
Alosetron does not affect the visceral perception of gastric distension in healthy subjects
1994
Traffic Noise and Risk of Myocardial Infarction
2004 Standout
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
Alvimopan, a selective peripherally acting μ‐opioid antagonist*
2005
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
2005 Standout
A review of central 5-HT receptors and their function
1999 Standout
Cisapride
1988
The Physiology of Glucagon-like Peptide 1
2007 Standout
The effects of the opiate antagonist naloxone on measures of cellular immunity during rest and brief psychological stress
1995
Effects of naloxone on nitrous oxide actions in healthy volunteers
1999
Esophageal Chest Pain: Current Controversies in Pathogenesis, Diagnosis, and Therapy
1989
Comparison of the Antinociceptive Effects Induced by Electroacupuncture and Transcutaneous Electrical Nerve Stimulation in the Rat
1992
Neurohypophyseal Secretion in Response to Cholecystokinin but Not Meal-Induced Gastric Distention in Humans
1989
Diclofenac Sodium
1988
Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry.
2004 Standout
Does experimental pain response vary across the menstrual cycle? A methodological review
2006
Effect of gastrointestinal peptides on ingestion in old and young mice
1988
Gastrointestinal Dysmotility: Clinical Consequences and Management of the Critically Ill Patient
2011
Association between Medications That Relax the Lower Esophageal Sphincter and Risk for Esophageal Adenocarcinoma
2000
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
Postsynaptic Signaling via the μ-Opioid Receptor: Responses of Dorsal Horn Neurons to Exogenous Opioids and Noxious Stimulation
2000
Effect of Six Weeks of Treatment With Cisapride in Gastroparesis and Intestinal Pseudo obstruction
1989
Prokinetic agents for lower gastrointestinal motility disorders
1993
Irritable bowel syndrome and psychiatric illness
1990
Subpopulations of Gastric Myenteric Neurons Are Differentially Activated via Distinct Serotonin Receptors: Projection, Neurochemical Coding, and Functional Implications
1997
Meal-induced c-fos expression in brain stem is not dependent on cholecystokinin release
1993
Current and Potential Drugs for Treatment of Obesity
1999
Reversal of the Gastric Effects of Nicotine by Nitric Oxide Donor Treatment
2001
Abdominal Vagotomy Blocks the Satiety Effect of Cholecystokinin in the Rat
1981 Science
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Experimental Pain Models Reveal No Sex Differences in Pentazocine Analgesia in Humans
2004
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Physiological and Pathogenic Effects of Sound
1981
Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction
1989
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
The Neuropsychology of Anxiety
2003 Standout
The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro‐oesophageal reflux disease
1998
Opioid Complications and Side Effects
2008 Standout
Antinociceptive action of nitrous oxide is mediated by stimulation of noradrenergic neurons in the brainstem and activation of [alpha]2B adrenoceptors.
2000 StandoutNobel
Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis
1987
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Inhibition of food intake in response to intestinal lipid is mediated by cholecystokinin in humans
1999
Rapid development of tolerance to the behavioural actions of cholecystokinin
1983 Nature
Works of H Steinringer being referenced
Lack of systematic effects of the 5‐hydroxytryptamine 3 receptor antagonist ICS 205‐930 on gastric emptying and antral motor activity in patients with primary anorexia nervosa.
1991
Effects of oral cisapride on interdigestive jejunal motor activity, psychomotor function, and side-effect profile in healthy man
1987
Naloxone does not alter the perception of pain induced by electrical and thermal stimulation of the skin in healthy humans
1988
Effects of cisapride on postcibal jejunal motor activity
1989
Effects of 3‐days' intake of a sustained‐release preparation of the nitric oxide donor, isosorbide dinitrate, on oesophageal motility
1997
Effects of the prodrug loperamide oxide, loperamide, and placebo on jejunal motor activity
1992
Gastric emptying of semisolid meal unaltered by 3 days' administration of a sustained‐release preparation of the nitric oxide donor, isosorbide dinitrate
1997
Experimental pain induced by electrical and thermal stimulation of the skin in healthy man: sensitivity to 75 and 150 mg diclofenac sodium in comparison with 60 mg codeine and placebo.
1986
Effects of the 5-HT3 receptor antagonist, ICS 205-930, on oesophageal motor activity and on lower oesophageal sphincter pressure: a double-blind cross-over study.
1990
Cholecystokinin decreases appetite and activation evoked by stimuli arising from the preparation of a meal in man
1979
Effects of a 5‐hydroxytryptamine3 receptor antagonist (ICS 205‐930) on colonic motor activity in healthy men.
1989
Stimulatory effects of the synthetic enkephalin analogue FK 33-824 on colonic motor activity antagonized by naloxone.
1981
Effects of the 5‐HT3 receptor antagonist ICS 205‐930 on fat‐delayed gastric emptying and antral motor activity.
1990
Cholecystokinin octapeptide decreases intake of solid food in man
1982
Ceruletide increases threshold and tolerance to experimentally induced pain in healthy man
1982
Effects of cisapride on jejunal motor activity in fasting healthy humans
1986
Acoustically Evoked Esophageal Contractions and Defense Reaction
1979
Effects of graded oral doses of meptazinol and pentazocine in comparison with placebo on experimentally induced pain in healthy humans.
1983